Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.

被引：0
|
作者：
Park, J
Kim, K
Jung, W
Kim, S
Shin, J
机构：
[1] Gachon Med Sch, Inchon, South Korea
[2] Seonam Univ, Coll Med, Namwon, South Korea
[3] Inje Univ, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P34 / P34
页数：1
相关论文
共 50 条
  • [31] PHARMACOKINETICS AND PHARMACODYNAMICS OF A SINGLE INTRAVENOUS DOSE OF HM10760A IN HEALTHY KOREAN SUBJECTS.
    Kim, S.
    Lee, S.
    Yoon, S.
    Lim, K. S.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S81 - S82
  • [32] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S80 - S80
  • [33] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S31 - S31
  • [34] The pharmacokinetics of tesaglitazar (GALIDA™) in healthy male subjects.
    Ericsson, H
    Samuelsson, S
    Bergstrand, S
    Fryklund, L
    Hamrén, B
    Heijer, M
    Öhman, P
    DIABETOLOGIA, 2003, 46 : A292 - A292
  • [35] Pharmacokinetics of Tapentadol in Healthy Elderly and Young Subjects.
    Smit, J. W.
    Haeufel, T.
    Ravenstijn, P.
    Brett, M.
    Kleideiter, E.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [36] Effect of asoprisnil on the pharmacokinetics of triazolam and its metabolite in healthy female subjects.
    Lee, RD
    Mulford, D
    Witt, G
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P79 - P79
  • [37] THE EFFECT OF EVEROLIMUS (EVE) ON THE PHARMACOKINETICS (PK) OF MIDAZOLAM (MID) IN HEALTHY SUBJECTS.
    Urva, S.
    Bouillaud, E.
    Delaney, R.
    Jappe, A.
    Cheung, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S128 - S128
  • [38] Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects
    Dimmitt, DC
    Cramer, MB
    Keung, A
    Arumugham, T
    Weir, SJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (02) : 126 - 132
  • [39] Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects
    Dan C. Dimmitt
    Michael B. Cramer
    Anther Keung
    Thangam Arumugham
    Scott J. Weir
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 126 - 132
  • [40] Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
    Ford, S. L.
    Sutton, K.
    Lou, Y.
    Zhang, Z.
    Tenorio, A.
    Trezza, C.
    Patel, P.
    Spreen, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
12345